Importantly, a significant reduction in the in situ proliferation of ATMs was observed in the HFD-treated STAT6-deficient mice as compared with that of wild-type mice, demonstrating an important role of IL-4 in driving the local proliferation of ATMs in obesity. The gene discussed is STAT6; the disease is obesity disorder.